Clinical Trial Update: An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating zidovudine (AZT) for AIDS Dementia Complex in AIDS patients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids Dementia Complex
• HIV Infections

Drugs mentioned

• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: AIDS Dementia Complex, HIV Infections | Phase 3 | Status: COMPLETED